NCT03167398View on ClinicalTrials.gov

Fecal Microbiota Transplantation for Eradication of CRE

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

December 30, 2019

Study Completion Date

December 30, 2019

Conditions
Antibiotic Resistant StrainMicrobial Colonization
Interventions
BIOLOGICAL

Fecal Microbiota Transplantation

Patients able to swallow will be given capsulized FMT using 15 capsules a day for two consecutive days. Patients will be treated concomitantly with omeprazole 20mg once in the evening before FMT and daily for the next 2 days.

Trial Locations (1)

Unknown

Rambam Health Care Campus, Haifa

All Listed Sponsors
collaborator

Tel-Aviv Sourasky Medical Center

OTHER_GOV

lead

Rambam Health Care Campus

OTHER

NCT03167398 - Fecal Microbiota Transplantation for Eradication of CRE | Biotech Hunter | Biotech Hunter